Twist Bioscience Launches Custom MRD Panels for Cancer Assay Development
The new platform offers custom panel manufacturing in as little as one day to support development of tumor-informed MRD assays.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Abbott Blood Test Improves Detection of Residual Colorectal Cancer After Surgery
Abbott’s Oncodetect MRD test showed a 30% sensitivity improvement over existing methods for detecting colorectal cancer recurrence post-surgery, according to clinical data presented at ESMO 2026.
Molecular Diagnostics
Latest
WHO Grants Emergency Use Listing for Rapid Test Detecting Ebola and 15 Other Pathogens
The molecular test can identify multiple causes of fever from a single blood sample in about an hour, helping healthcare workers diagnose infections and respond to outbreaks more quickly.
Ambry Genetics Launches Whole Genome Sequencing Test Solution for Rare Diseases
The new testing solution integrates ongoing data reanalysis to re-evaluate variants as clinical gene-disease knowledge expands.
Read More
The Next Era of Diagnostic Stewardship
As molecular diagnostics expand what laboratories can detect, laboratories are placing greater emphasis on matching the breadth of testing to the patient and how the results will be used.
Read More
Federal Directive Spurs R&D Focus on Rapid Diagnostics for Vector-Borne Diseases
A new federal directive tasks HHS with launching rapid diagnostic R&D for vector-borne diseases, emphasizing decentralized molecular testing as part of a broader strategy to improve local pathogen surveillance.
Read More
10x Genomics, Fred Hutch Launch Cancer Diagnostics Research Collaboration
10x Genomics and Fred Hutchinson Cancer Center have launched a multi-project collaboration to study single cell and spatial profiling for cancer diagnostics, including biomarkers in bladder cancer and residual disease detection in AML.
Read More
Roche Adds Molecular Testing Capacity in Democratic Republic of Congo Amid Ebola Outbreak
Roche Diagnostics has supplied two molecular testing systems and is training laboratory staff in the Democratic Republic of Congo to expand PCR testing capacity for Bundibugyo virus amid rising Ebola testing demand.
Read More
Cerenome Launches Two CSF Molecular Profiling Tests for CNS Cancers
Cerenome has launched two CSF-based molecular profiling tests for CNS cancers, offering DNA and RNA sequencing panels to evaluate primary, metastatic, and hematologic malignancies in the central nervous system.
Read More
Baylor Genetics Named Lead Sequencing Partner for Florida Newborn Screening Pilot
Baylor Genetics has been named lead sequencing provider for Florida’s five-year Sunshine Genetics Pilot, which will use whole-genome sequencing to screen newborns for nearly 900 genetic conditions statewide.
Read More
Study Validates High-Throughput Proteomics for Measuring Endothelin-1
A peer-reviewed study found that Olink proximity extension assay technology correlates with ELISA for measuring endothelin-1 in coronary artery plasma, supporting its use for high-throughput proteomics in clinical research.
Read More
Pillar Biosciences Launches 80-Gene NGS Panel for Myeloid Malignancies
Pillar Biosciences has introduced the oncoReveal Myeloid v2 Panel, expanding its NGS assay from 58 to 80 genes and enhancing FLT3-ITD detection while maintaining existing laboratory workflows.
Read More
Population Proteomics Study Identifies Over 2,500 New Genetic-Protein Links
Researchers from the PRECISE-SG100K study have identified over 2,500 new genetic-protein associations by analyzing data from 10,000 participants, advancing biomarker discovery in large-scale, multi-ethnic cohorts.
Read More
Renew Biotechnologies, Mayo Clinic Partner to Evaluate cfDNA Biomarker in Multiple Sclerosis
Renew Biotechnologies and Mayo Clinic have partnered to evaluate NeuroLens, a cfDNA-based test, for monitoring central nervous system injury and disease progression in multiple sclerosis and related neuroimmunologic conditions.
Read More
Roche Launches Newborn Screening Test for Three Severe Genetic Conditions
Roche subsidiary TIB MOLBIOL has launched a CE-marked newborn screening kit that simultaneously tests for spinal muscular atrophy, severe combined immunodeficiency, and sickle cell disease in laboratories across Europe.
Read More
FDA Clears Qiagen Gram-Negative Bloodstream Infection Panel
The FDA has cleared Qiagen’s QIAstat-Dx BCID GN Plus AMR Panel, enabling U.S. labs to detect 13 gram-negative bacterial pathogens and 18 resistance markers in about one hour on the QIAstat-Dx system.
Read More
Coffee Mug Powers Portable Test for Seven Mosquito-Borne Viruses
University of Florida researchers have developed a portable diagnostic device that detects and differentiates seven mosquito-borne viruses in under an hour, offering rapid results without the need for traditional lab equipment.
Read More
DNA Test Diagnoses Inherited Muscle Diseases Missed by Standard Testing
Garvan Institute researchers have developed a long-read nanopore DNA test that screens over 300 genes, diagnosing inherited muscle diseases in cases missed by standard testing.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- ...
- 112